Search results for: 'd2cb intelligent pharma'
- Did you mean
- dect intelligent pharma
- dock intelligent pharma
- Related search terms
- pharmaceutical-industry-in-ghana-and-nigeria-18447
- pharmaceutical membrane filtration market analysis by product mce coated cellulose acetate nylon p1df membrane technique
- pharmaceutical R&D service market
- pharmaceutical industry market size of singapor
- intelligent transportation system bu market
-
27 Jan 2021  |  North America  |  Tracker
Artificial Intelligence Powering the Global Medical Imaging Market
Efficiency Tools and Workflow Optimization to Drive Future Growth Potential
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...
$7,500.00
Special Price $5,625.00 save 25 %
-
14 Mar 2017  |  North America  |  Market Research
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...
$1,500.00
Special Price $1,125.00 save 25 %
-
21 Dec 2022  |  North America  |  Market Research
Growth Opportunities and Innovative Use Cases for AI in Clinical Trials
Integrating Real-world Insights into Intelligent Platforms to Enable Patient-centric Trial Design
As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...
$2,450.00
Special Price $1,837.50 save 25 %
-
01 Aug 2018  |  North America  |  Market Research
Artificial Intelligence Virtual Assistants in Healthcare—From Echo to the Enterprise
Improved Workflow, Operational Efficiency, and Customer Journey Will be Available to All Stakeholders
Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportun...
$1,500.00
Special Price $1,125.00 save 25 %
-
14 Feb 2017  |  North America  |  Market Research
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...
$1,500.00
Special Price $1,125.00 save 25 %
-
11 Apr 2019  |  North America  |  Market Research
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...
$1,500.00
Special Price $1,125.00 save 25 %
-
19 Jun 2014  |  North America  |  Market Research
Pharmaceutical Industry in Ghana and Nigeria
A Ripe Business Opportunity for Big Pharma and Generic Pharma Companies
This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2020  |  North America  |  Frost Radar
Frost Radar™: Intelligent Imaging Analysis Systems, 2020
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Healthcare facilities across the globe have been facing twin challenges in terms of rising patient imaging volumes attributed to the growing prevalence of chronic diseases and acute shortage of radiologists and clinicians required to review them. The current practice of manual viewing and grading of the medical images by the radiologists and clinic...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 May 2018  |  North America  |  Market Research
Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020
Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials
Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, t...
$3,000.00
Special Price $2,250.00 save 25 %
-
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %